MXPA03011843A - Un nuevo receptor copulado a proteina g, gave3. - Google Patents

Un nuevo receptor copulado a proteina g, gave3.

Info

Publication number
MXPA03011843A
MXPA03011843A MXPA03011843A MXPA03011843A MXPA03011843A MX PA03011843 A MXPA03011843 A MX PA03011843A MX PA03011843 A MXPA03011843 A MX PA03011843A MX PA03011843 A MXPA03011843 A MX PA03011843A MX PA03011843 A MXPA03011843 A MX PA03011843A
Authority
MX
Mexico
Prior art keywords
gave3
novel
proteins
gave
protein
Prior art date
Application number
MXPA03011843A
Other languages
English (en)
Inventor
Xia Tai-He
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MXPA03011843A publication Critical patent/MXPA03011843A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)

Abstract

Se proporcionan nuevos polipeptidos de GAVE3, proteinas y moleculas de acido nucleico. Ademas de proteinas GAVE3 de longitud total aisladas, se dan a conocer proteinas de fusion de GAVE3 aisladas, peptidos antigenicos y anticuerpos anti-GAVE3. Se dan a conocer GAVE3, vectores de expresion recombinantes, celulas hospedadoras en las cuales se han introducido los vectores de expresion y animales no humanos transgenicos en los cuales se ha introducido o fragmentado un gen GAVE3. Se proporcionan tambien metodos de diag-nostico, de escrutinio y terapeuticos que utilizan composiciones de la invencion.
MXPA03011843A 2001-06-22 2002-06-21 Un nuevo receptor copulado a proteina g, gave3. MXPA03011843A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/886,041 US20030059869A1 (en) 2001-06-22 2001-06-22 Novel G protein-coupled receptor, GAVE3
PCT/US2002/019490 WO2003000846A2 (en) 2001-06-22 2002-06-21 A novel g protein-coupled receptor, gave 3

Publications (1)

Publication Number Publication Date
MXPA03011843A true MXPA03011843A (es) 2004-03-26

Family

ID=25388250

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03011843A MXPA03011843A (es) 2001-06-22 2002-06-21 Un nuevo receptor copulado a proteina g, gave3.

Country Status (10)

Country Link
US (1) US20030059869A1 (es)
JP (1) JP2005500036A (es)
KR (1) KR20040022432A (es)
AR (1) AR036104A1 (es)
BR (1) BR0210937A (es)
CA (1) CA2451686A1 (es)
IL (1) IL159477A0 (es)
MX (1) MXPA03011843A (es)
NO (1) NO20035670L (es)
WO (1) WO2003000846A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0717112B1 (pt) * 2006-09-29 2017-04-18 Basf Se processo para a regeneração de um auxiliar de filtração

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors

Also Published As

Publication number Publication date
JP2005500036A (ja) 2005-01-06
WO2003000846A3 (en) 2004-03-04
US20030059869A1 (en) 2003-03-27
BR0210937A (pt) 2006-10-24
AR036104A1 (es) 2004-08-11
NO20035670L (no) 2004-02-19
KR20040022432A (ko) 2004-03-12
WO2003000846A2 (en) 2003-01-03
IL159477A0 (en) 2004-06-01
NO20035670D0 (no) 2003-12-18
CA2451686A1 (en) 2003-01-03

Similar Documents

Publication Publication Date Title
WO1999066025A3 (en) Mtbx protein and nucleic acid molecules and uses therefor
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
NO20020861D0 (no) PD-1, en reseptor for B7-4, og anvendelser derav
EP1009752A4 (en) NOVEL TANGO-77 PROTEIN FAMILY MOLECULES AND USES THEREOF
WO2002070652A3 (en) Novel molecules of the card-related protein family and uses thereof
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO2000052047A3 (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
WO2002044354A3 (en) Molecules of the card-related protein family and uses thereof
WO2001000826A3 (en) Novel molecules of the card-related protein family and uses thereof
WO2000019988A8 (en) NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
EP1208196A4 (en) NEW SECRETINE FAMILY GPCR TYPE 15571 MOLECULE AND USES THEREOF
WO2000012544A3 (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
WO2002070657A8 (en) 93870, a human g-protein coupled receptor and uses therefor
WO2001018216A3 (en) 26176, a novel calpain protease and uses thereof
WO2002068591A3 (en) G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereof
WO2000008045A3 (en) Novel molecules of the tango-93-related protein family and uses thereof
WO2002038767A3 (en) G protein-coupled receptor protein and nucleic acid molecules and uses therefor
WO2001030971A3 (en) Novel molecules and the card-related protein family and uses thereof
WO1999054437A3 (en) Novel molecules of the t125-related protein family and uses thereof
WO2001077151A3 (en) Fdrg proteins and nucleic acid molecules and uses therefor
WO2003029434A3 (en) Novel molecules of the hkid-1-related protein family and uses thereof
WO2002085939A8 (en) Novel molecules of the card-related protein family and uses thereof
MXPA03011843A (es) Un nuevo receptor copulado a proteina g, gave3.
WO2001085768A3 (en) G-protein coupled receptors and uses therefor
WO2003029413A3 (en) A novel g protein-coupled receptor, gave 10